Search

Compugen Ltd

Uždarymo kaina

2.35 0.43

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.23

Max

2.37

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

5.95

64.641

Pelnas, tenkantis vienai akcijai

-0.08

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+113.68% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-03

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-45M

225M

Ankstesnė atidarymo kaina

1.92

Ankstesnė uždarymo kaina

2.35

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-30 23:56; UTC

TG Therapeutics Inc shares are lower in after-market hours, with no specific news identified for the decline amid broader market uncertainty over interest rates.

2026-07-30 23:56; UTC

PennyMac Mortgage Investment Trust shares are higher in after-market trading. No specific news was identified to explain the movement.

2026-07-30 23:56; UTC

Correlated Moves

Ovintiv Inc shares declined in after-market trading, reflecting broader energy sector sentiment amid uncertainty following the Federal Reserve's interest rate decision.

2026-07-30 23:56; UTC

Mattel Inc shares are higher in after-market trading, recovering from an initial decline and remaining above the 20-day moving average.

2026-07-30 23:56; UTC

MSCI Inc shares are trading higher in after-market hours, recovering from earlier declines amid broader market uncertainty over Federal Reserve interest rate decisions.

2026-07-30 23:56; UTC

Correlated Moves
ETF Constituents

Vanguard Mid-Cap ETF gains in after-market trading, supported by strong performances from Dexcom and Monolithic Power Systems, among others.

2026-07-30 23:56; UTC

Shake Shack Inc shares are trading lower in after-market hours. Broader market uncertainty follows the Federal Reserve's decision to maintain interest rates.

2026-07-30 23:56; UTC

Correlated Moves

Kulicke and Soffa Industries Inc shares advanced in after-market trading, reflecting a broader positive trend in the semiconductor sector.

2026-07-30 23:56; UTC

Correlated Moves

SiTime Corp shares are rising in after-market trading, boosted by positive momentum in the semiconductor sector, despite being below their 20-day moving average.

2026-07-30 23:56; UTC

Albertsons Companies Inc shares are higher in after-market trading, rebounding from earlier session lows with no specific news to explain the movement.

2026-07-30 23:56; UTC

Shares of Blue Owl Capital are higher in after-market hours, trading near the upper end of their one-month range and above the 20-day moving average.

2026-07-30 23:56; UTC

News

Old Dominion Freight Line shares lower in after-market hours after UBS raised its price target to $228 while maintaining a Neutral rating.

2026-07-30 23:56; UTC

Incyte Corp shares are lower in after-market trading, continuing a trend of declines since Thursday's close amid broader market pressures.

2026-07-30 23:56; UTC

GitLab Inc. shares are lower in after-market trading, amid broader market uncertainty following recent Federal Reserve decisions and ongoing geopolitical tensions.

2026-07-30 23:56; UTC

Correlated Moves

Campbell Soup Co shares are higher in after-market trading, gaining traction following a slight initial dip. The stock aligns with trends in the packaged foods sector.

2026-07-30 23:56; UTC

Correlated Moves
ETF Constituents

Vanguard Value ETF gains slightly after-market, supported by top holdings Intel and Exxon Mobil. The ETF remains near the upper end of its one-month trading range.

2026-07-30 23:56; UTC

Social Media

NIO Inc shares are higher in after-market trading, continuing a five-session gain. Social media highlights a price comparison with AUDI's Q9 model.

2026-07-30 23:56; UTC

Sherwin-Williams shares are higher in after-market trading, maintaining a position above its 20-day moving average and near the top of its one-month range.

2026-07-30 23:56; UTC

Coursera Inc. shares are roughly flat in after-market trading, remaining below their 20-day moving average and near the lower end of their one-month range.

2026-07-30 23:56; UTC

Correlated Moves
ETF Constituents

Energy Select Sector SPDR Fund trades higher after market close, driven by strong performances from ExxonMobil, Chevron, and ConocoPhillips, along with rising WTI crude prices.

2026-07-30 23:56; UTC

Correlated Moves

Rambus Inc shares are higher in after-market trading, supported by a rise in the semiconductor sector and Monolithic Power Systems' significant price increase.

2026-07-30 23:56; UTC

News

DICK'S Sporting Goods Inc. sees gains in after-market trading, supported by solid fundamentals and recognition as a value stock despite mixed performance momentum.

2026-07-30 23:56; UTC

Salesforce shares are lower in after-market trading, continuing a decline since Thursday's close amid market uncertainty following the Federal Reserve's interest rate decision.

2026-07-30 23:56; UTC

News

Viking Therapeutics Inc. shows a modest gain in after-market hours amid a wave of biopharmaceutical mergers, including Vertex's $10 billion acquisition of Crinetics.

2026-07-30 23:56; UTC

Correlated Moves

Quanta Services Inc shares are higher in after-market trading, reflecting broader sector gains alongside nVent Electric PLC's rise amid recent macroeconomic developments.

2026-07-30 23:56; UTC

News

Check Point Software Technologies reported earnings of $2.55 per share, surpassing expectations of $2.45. Shares are little changed in after-market trading.

2026-07-30 23:52; UTC

Japan Retail Sales Expected to Rise 3.1% YoY for June 2026 Amidst Stable Consumer Sentiment and Recent Market Uncertainty

2026-07-30 23:52; UTC

Japan's Industrial Production MoM data for June 2026 expected to rise by only 0.7%, amid cautious investor sentiment following recent underperformance and global supply chain uncertainties.

2026-07-30 23:52; UTC

Japan's unemployment rate holds steady at 2.5% for June, signaling stability in labor conditions despite slight declines in overall employment and rising inflation concerns.

2026-07-30 23:52; UTC

Upcoming ADP Employment Change report on August 5 raises concerns as June job additions fall short of expectations amid cautious market optimism.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

113.68% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  113.68%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat